Curai Health, a Palo Alto, Calif.-based virtual care company using AI, raised $27.5m in Series B funding.
The round, which brings total funding to approximately $57m, was led by Morningside Ventures with participation from existing investors General Catalyst and Khosla Ventures. As part of today’s deal, Stephen Bruso from Morningside Ventures will join its board.
The company will use the funding to continue innovating its technology and expand its services and footprint more broadly.
Founded by Neal Khosla and Xavier Amatriain in 2017, Curai Health provides chat-based primary care that centers around patients. Combining clinical care, artificial intelligence (AI) and clinical data sources, the learning healthcare system creates a sustainable and scalable model that can meet the demands of an exploding global population.
Previously available only direct-to-consumer, Curai Health also announced today that it will now support enterprise partnerships, including payers, employers and public-sector organizations.
Where available in California, Curai Health is accessible to patients 24/7, supporting them with as many questions and follow ups as needed. Patient care teams are led by U.S. licensed physicians and medically trained Clinical Associates, who are both supported by the AI. To date, more than 350,000 patient visits have occurred on the platform.